<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01287403</url>
  </required_header>
  <id_info>
    <org_study_id>10.14 MET</org_study_id>
    <nct_id>NCT01287403</nct_id>
  </id_info>
  <brief_title>Response of Alkylresorcinols to Different Cereals</brief_title>
  <official_title>Response of Alkylresorcinols and Other Biomarkers to Different Cereals</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nestlé</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Nestlé</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cereal grains contain a wide variety of different phytochemicals which may play different
      roles in physiology. Their response in plasma and urine after a meal is poorly defined for
      most cereals. This study will investigate the plasma response and urinary excretion of cereal
      compounds after eating 6 different types of cereal preparation, with a focus on
      alkylresorcinols.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This was a cross-over, randomized, double blind study with 6 arms (flours of different
      composition). Thirteen subjects completed the trial, where 100 g of each flour, mixed with
      300 mL milk, was fed to all subjects.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>January 2011</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">August 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Plasma Alkylresorcinol Compounds</measure>
    <time_frame>From 0 to 48 h post dose.</time_frame>
    <description>Area under the curve (AUC) over baseline of alkylresorcinol compounds are measured for the 6 interventional arms. Time points are: t = 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 14, 24 and 48 h after product intake.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Plasma and Urinary Betaine</measure>
    <time_frame>From 0 to 48 hours post dose</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Phenolic Acids</measure>
    <time_frame>0-48 h post dose</time_frame>
    <description>Phenolic acids in plasma and urine</description>
  </secondary_outcome>
  <number_of_arms>6</number_of_arms>
  <enrollment type="Actual">14</enrollment>
  <condition>Healthy</condition>
  <arm_group>
    <arm_group_label>Refined wheat flour</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>A negative control flour to serve as a reference.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Esterase wholegrain wheat flour</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Wholegrain wheat flour treated with esterases to release phenolics (positive control for phenolic acids)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wholegrain wheat flour</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Flour with unknown response</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liquid whole grain wheat flour</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test flour with unknown response.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Wholegrain barley flour</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test flour with unknown response.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Liquid wholegrain barley flour</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Test flour with unknown response.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Refined wheat flour</intervention_name>
    <description>A treated cereal flour mixed with milk.</description>
    <arm_group_label>Esterase wholegrain wheat flour</arm_group_label>
    <arm_group_label>Wholegrain wheat flour</arm_group_label>
    <arm_group_label>Liquid whole grain wheat flour</arm_group_label>
    <arm_group_label>Wholegrain barley flour</arm_group_label>
    <arm_group_label>Liquid wholegrain barley flour</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Esterase wholegrain wheat flour</intervention_name>
    <description>A treated cereal flour mixed with milk.</description>
    <arm_group_label>Refined wheat flour</arm_group_label>
    <arm_group_label>Wholegrain wheat flour</arm_group_label>
    <arm_group_label>Liquid whole grain wheat flour</arm_group_label>
    <arm_group_label>Wholegrain barley flour</arm_group_label>
    <arm_group_label>Liquid wholegrain barley flour</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Wholegrain wheat flour</intervention_name>
    <description>A treated cereal flour mixed with milk.</description>
    <arm_group_label>Refined wheat flour</arm_group_label>
    <arm_group_label>Esterase wholegrain wheat flour</arm_group_label>
    <arm_group_label>Liquid whole grain wheat flour</arm_group_label>
    <arm_group_label>Wholegrain barley flour</arm_group_label>
    <arm_group_label>Liquid wholegrain barley flour</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Liquid whole grain wheat flour</intervention_name>
    <description>A treated cereal flour mixed with milk.</description>
    <arm_group_label>Refined wheat flour</arm_group_label>
    <arm_group_label>Esterase wholegrain wheat flour</arm_group_label>
    <arm_group_label>Wholegrain wheat flour</arm_group_label>
    <arm_group_label>Wholegrain barley flour</arm_group_label>
    <arm_group_label>Liquid wholegrain barley flour</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Wholegrain barley flour</intervention_name>
    <description>A treated cereal flour mixed with milk.</description>
    <arm_group_label>Refined wheat flour</arm_group_label>
    <arm_group_label>Esterase wholegrain wheat flour</arm_group_label>
    <arm_group_label>Wholegrain wheat flour</arm_group_label>
    <arm_group_label>Liquid whole grain wheat flour</arm_group_label>
    <arm_group_label>Liquid wholegrain barley flour</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Liquid wholegrain barley flour</intervention_name>
    <description>A treated cereal flour mixed with milk.</description>
    <arm_group_label>Refined wheat flour</arm_group_label>
    <arm_group_label>Esterase wholegrain wheat flour</arm_group_label>
    <arm_group_label>Wholegrain wheat flour</arm_group_label>
    <arm_group_label>Liquid whole grain wheat flour</arm_group_label>
    <arm_group_label>Wholegrain barley flour</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy

          -  Normal-overweight (BMI 19-28 kg/m2)

          -  Non-smokers

        Exclusion Criteria:

          -  Regular consumers of wholegrain cereals

          -  Allergy to cereal or milk products
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>55 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Alastair B Ross, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Nestlé</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>NESTEC / Clinical Development Unit / Metabolic Unit</name>
      <address>
        <city>Lausanne</city>
        <state>Vaud</state>
        <zip>1000</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 30, 2011</study_first_submitted>
  <study_first_submitted_qc>January 31, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 1, 2011</study_first_posted>
  <results_first_submitted>April 9, 2013</results_first_submitted>
  <results_first_submitted_qc>July 11, 2013</results_first_submitted_qc>
  <results_first_posted type="Estimate">August 14, 2013</results_first_posted>
  <last_update_submitted>July 11, 2013</last_update_submitted>
  <last_update_submitted_qc>July 11, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 14, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Nestlé</investigator_affiliation>
    <investigator_full_name>CDUadmin</investigator_full_name>
    <investigator_title>Dr Beaumont</investigator_title>
  </responsible_party>
  <keyword>Cereals</keyword>
  <keyword>Alkylresorcinols</keyword>
  <keyword>Betaine</keyword>
  <keyword>Phenolics</keyword>
  <keyword>Plasma and urine cereal phytochemicals</keyword>

  <clinical_results>

    <participant_flow>
      <recruitment_details>14 healthy subjects were recruited within the staff of the Nestle Research Center. After being informed, by written and orally, on the aims, methods, risk/benefit ratio for the study, they signed an informed consent form and underwent a medical visit screening as per protocol</recruitment_details>
      <pre_assignment_details>Thirteen subjects completed the trial, where 100 g of each flour, mixed with 300 mL milk, was fed to all subjects.
Subjects avoided foods containing whole grains for one week prior, and 36 h before the start of each treatment, to avoid all phenolic-rich foods (e.g. coffee, tea, chocolate, most fruits and vegetables).</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>Six Products (Flours) Assigned Randomly (Cross Over)</title>
          <description>In a crossover design, all subjects were administered the 6 following products in a randomized order:
Esterase wholegrain wheat flour: a cereal flour treated with esterases to release phenolics (positive control for phenolic acids).
Refined wheat flour: a treated cereal flour mixed with milk (negative control).
Liquid whole grain wheat flour: a treated cereal flour mixed with milk.
Liquid wholegrain barley flour: a treated cereal flour mixed with milk.
Wholegrain wheat flour: a treated cereal flour mixed with milk.
Wholegrain barley flour: a treated cereal flour mixed with milk.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Diet Restriction (7 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>1st Intervention (1 Day)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="14"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13">The adverse event was linked to the intake of &quot;refined wheat flour&quot;</participants>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Adverse Event</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
        <period>
          <title>Washout 7 Days</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>2nd Intervention (1 Day)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout (7 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>3rd Intervention (1 Day)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout (7 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>4th Intervention (1 Day)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout (7 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>5th Intervention (1 Day)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>Washout (7 Days)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>6th and Last Intervention (1 Day)</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="13"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>All subjects were recruited within the staff of the Nestlé Research Center between February and June 2011.</population>
      <group_list>
        <group group_id="B1">
          <title>Entire Study Population</title>
          <description>Includes groups randomized to receive either esterase wholegrain wheat flour first or liquid wholegrain wheat flour first or liquid wholegrain barley flour first or refined wheat flour first or wholegrain wheat flour first or wholegrain barley flour first</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="14"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age, Customized</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt; 18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>between 18 and 55 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt; 55 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Switzerland</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Plasma Alkylresorcinol Compounds</title>
        <description>Area under the curve (AUC) over baseline of alkylresorcinol compounds are measured for the 6 interventional arms. Time points are: t = 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 14, 24 and 48 h after product intake.</description>
        <time_frame>From 0 to 48 h post dose.</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Esterase Whole Grain Wheat Flour</title>
            <description>A cereal flour treated with esterase to release phenolics (positive control for phenolic acids).</description>
          </group>
          <group group_id="O2">
            <title>Refined Wheat Flour</title>
            <description>A treated cereal flour mixed with milk(negative control).</description>
          </group>
          <group group_id="O3">
            <title>Liquid Whole Grain Wheat Flour</title>
            <description>A treated cereal flour mixed with milk.</description>
          </group>
          <group group_id="O4">
            <title>Liquid Wholegrain Barley Flour</title>
            <description>A treated cereal flour mixed with milk.</description>
          </group>
          <group group_id="O5">
            <title>Wholegrain Wheat Flour</title>
            <description>A treated cereal flour mixed with milk.</description>
          </group>
          <group group_id="O6">
            <title>Wholegrain Barley Flour</title>
            <description>A treated cereal flour mixed with milk.</description>
          </group>
        </group_list>
        <measure>
          <title>Plasma Alkylresorcinol Compounds</title>
          <description>Area under the curve (AUC) over baseline of alkylresorcinol compounds are measured for the 6 interventional arms. Time points are: t = 0.5, 1, 2, 3, 4, 5, 6, 7, 8, 10, 12, 14, 24 and 48 h after product intake.</description>
          <units>nmol/L*h</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="13"/>
                <count group_id="O2" value="13"/>
                <count group_id="O3" value="13"/>
                <count group_id="O4" value="13"/>
                <count group_id="O5" value="13"/>
                <count group_id="O6" value="13"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="19357" spread="7509"/>
                    <measurement group_id="O2" value="1548" spread="698"/>
                    <measurement group_id="O3" value="17307" spread="5914"/>
                    <measurement group_id="O4" value="5385" spread="2642"/>
                    <measurement group_id="O5" value="17139" spread="6386"/>
                    <measurement group_id="O6" value="5634" spread="2478"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Plasma and Urinary Betaine</title>
        <time_frame>From 0 to 48 hours post dose</time_frame>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Phenolic Acids</title>
        <description>Phenolic acids in plasma and urine</description>
        <time_frame>0-48 h post dose</time_frame>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>This adverse event occurred during the 1st intervention. The subject did not wish to go on with the study.</time_frame>
      <group_list>
        <group group_id="E1">
          <title>Refined Wheat Flour</title>
          <description>A treated cereal flour mixed with milk (negative control).</description>
        </group>
        <group group_id="E2">
          <title>Esterase Wholegrain Wheat Flour</title>
          <description>A cereal flour treated with esterases to release phenolics (positive control for phenolic acids)</description>
        </group>
        <group group_id="E3">
          <title>Liquid Whole Grain Wheat Flour</title>
          <description>A treated cereal flour mixed with milk.</description>
        </group>
        <group group_id="E4">
          <title>Liquid Wholegrain Barley Flour</title>
          <description>A treated cereal flour mixed with milk.</description>
        </group>
        <group group_id="E5">
          <title>Wholegrain Wheat Flour</title>
          <description>A treated cereal flour mixed with milk.</description>
        </group>
        <group group_id="E6">
          <title>Wholegrain Barley Flour</title>
          <description>A treated cereal flour mixed with milk.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <default_vocab>Vomiting</default_vocab>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E4" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E6" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Gastrointestinal disorders</title>
            <event_list>
              <event>
                <sub_title>Vomiting</sub_title>
                <description>The subject complain of nausea in the hour following the product intake and vomitted 8 hours later.</description>
                <counts group_id="E1" events="1" subjects_affected="1" subjects_at_risk="14"/>
                <counts group_id="E2" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E3" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E4" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E5" events="0" subjects_affected="0" subjects_at_risk="14"/>
                <counts group_id="E6" events="0" subjects_affected="0" subjects_at_risk="14"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dr Maurice Beaumont, MD, PhD</name_or_title>
      <organization>Clinical Development Unit / Metabolic Unit</organization>
      <phone>+41217858054</phone>
      <email>maurice.beaumont@rdls.nestle.com</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

